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Adherencia.
Mobile applications (apps) are a promising approach for 
improving self-management behaviors in patients with asthma, 
as they can be easily integrated into adolescents’ and adults’ 
everyday lives [1,2]. Smart mobile devices have the advantages 
of being personal, portable, connected, (increasingly) low cost 
and computationally powerful. It is hypothesized that through 
gamification and patient-to-patient (peer) interaction [3], 
apps may be ubiquitous solutions capable of improving and 
maintaining self-management behaviors in the long term and 
impacting large numbers of patients, especially adolescents 
and adults, who are considered the demographic groups most 
comfortable with smartphones. However, current use of smart 
devices, social networks, and apps among patients with asthma 
remains unexplored, as does the interest of these groups in asthma 
apps. The lack of published studies on the use of mHealth in 
allergic diseases was highlighted in the recent position paper 
of the European Academy of Allergy and Clinical Immunology 
(EAACI) [1]. Thus, we aimed to investigate the use of smart 
devices, social networks, and apps, as well as the use of and 
interest in asthma apps among adolescents and adults with asthma.
We based our investigation on data from a prospective 
observational study focusing on adherence to asthma inhalers 
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among adolescents and adults with persistent asthma [4]. 
Patients were recruited during medical visits by convenience 
sampling at 25 allergy, pulmonology, and pediatric outpatient 
clinics in Portugal. The study was approved by the local 
ethics committees. Patients were included if they had 
persistent asthma, were at least 13 years old, and had an active 
prescription for an inhaled controller medication. Patients were 
surveyed regarding ownership of cell phones (simple devices 
for voice calls and text messages), smartphones (combined 
phone, web browser, and computer capabilities), and tablets. To 
characterize the use of smart mobile devices, we used 5 items 
of the Media and Technology Usage and Attitudes Scale (use 
GPS, browse the web, take pictures, gaming, check social 
networks) [5]. We also included questions on the following: 
patients’ use of social networks; previous download/use of 
general, health/fitness, or asthma apps; willingness to use 
an app to monitor asthma and to improve inhaler adherence; 
and willingness to participate in studies evaluating apps for 
asthma. Descriptive statistics were used to describe the data 
collected, and the 2 test was applied to compare proportions 
between adolescents and adults.
This study included 336 participants: 104 (31%) adolescents 
and 232 (69%) adults. Participants were mostly female (62%), 
and their mean (SD) age was 34.3 (19.2) years (Supplementary 
material). Results on use of social networks, mobile devices, 
and apps are summarized in the Figure. Social networks were 
used by almost all adolescents (98%) and by 78% of adults 
(P<.001): Instagram was more common in adolescents (64%) 
and Facebook in adults (74%). Only 5% of participants have 
ever referred to their asthma in social networks.
A total of 288 (86%) participants owned a smart mobile 
device: 274 (82%) a smartphone and 71 (21%) a tablet. The 
rate of smart device ownership was higher among adolescents 
(96% vs. 81%, P<.001), as was the frequency of use of smart 
devices in activities such as browsing the web, taking pictures, 
gaming, and checking social networks (P<.015).
Most adolescents (93%) and adults (62%) had downloaded/
used an app (P<.001), with 87% of adolescents using apps 
Figure. Figure. Use of social networks, mobile devices, and mobile applications (n=336). 
*Significant differences between adolescents and adults.
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daily, in contrast with 54% of adults (P<.001). However, only 
one-third of participants had ever used a health/fitness app, 
with 3% reporting the use of an asthma app. Nevertheless, 
around two-thirds of patients would be interested in using 
an asthma app—specifically an app to improve inhaler 
adherence—as well as in participating in studies for validation 
of asthma apps.
The rates of adolescents and adults owning a smartphone 
in this study are in line with those described among patients 
with conditions such as allergic respiratory diseases and 
mental health disorders [6-8]. Furthermore, our results are 
in accordance with findings in the general population in 
Europe [9] and the USA [10].
The use of social networks among patients with asthma 
followed the pattern observed in the general population, 
with adolescents engaging more with social networks than 
adults [11]. In addition, the dominant online platforms differed 
between age groups, in line with other studies: Instagram for 
adolescents (61% to 72% [10,12]) and Facebook for adults 
(53% to 82% [11-13]).
Regardless of the age group, about three-quarters of the 
patients with asthma had downloaded/used an app, although 
only one-third had used a health/fitness app. These findings 
are in line with reported frequencies for general apps (71% 
to 79% [7,8]) and health/fitness (28% [8]) apps, although in 
the lower end of the range found in the literature. The most 
discouraging result was that only 3% of the participants had 
ever used an app directly related to their asthma. Indeed, 
asthma apps capture <1% of the target market [14]. This 
contrasts with other app market segments, such as diabetes, 
mental health, and nutrition, which have been able to attract 
and retain users to a much greater degree [7,14]. This result 
may be explained by the lack of knowledge of existing apps 
and of their benefits for asthma management among patients’ 
and health professionals. However, it may also be related to 
the fact that most asthma apps are exclusively tracker apps, 
do not provide behavior change support/coaching solutions, 
and do not enable automated data input or personalized 
feedback [2,14].
Importantly, about two-thirds of patients expressed interest 
in using an app to manage their asthma, namely, to improve 
inhaler adherence, a well-known problem among patients 
with asthma. This interest is similar to that reported by 
patients with other health conditions [6,15]. Moreover, two-
thirds of patients reported being interested in participating in 
studies for validation of asthma apps, which may reflect the 
sampling method and voluntary participation in the study. The 
contrasting findings of low use but high interest in asthma apps, 
may be linked to previously reported reasons and highlight the 
need to develop asthma apps supported by evidence-based, 
user-informed, and attractive approaches [1,2,14].
Our sample comprised adolescents and young and middle-
aged adults with persistent asthma, who were mostly recruited 
from secondary health care centers. Population studies 
with larger samples of patients with an extended age range 
(including children and older adults) should be conducted 
in the future. The patients’ allergic profile was not collected, 
although it might play a role in mHealth-related habits. Future 
studies could also address this issue.
Most patients had access to smart devices and apps, 
although only one-third were engaged with health/fitness apps. 
Despite this low engagement, two-thirds were interested in 
using apps to support asthma management as part of their care. 
Smartphone and apps are integrated in patients’ routines and 
might be promising tools for improving asthma monitoring 
and management.
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